BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutiérrez-hoya A, Soto-cruz I. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins. Cells 2020;9:2297. [DOI: 10.3390/cells9102297] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei W, Xie LZ, Xia Q, Fu Y, Liu FY, Ding DN, Han FJ. The role of vaginal microecology in the cervical cancer. J Obstet Gynaecol Res 2022. [PMID: 35815344 DOI: 10.1111/jog.15359] [Reference Citation Analysis]
2 Bhattacharjee R, Dey T, Kumar L, Kar S, Sarkar R, Ghorai M, Malik S, Jha NK, Vellingiri B, Kesari KK, Pérez de la Lastra JM, Dey A. Cellular landscaping of cisplatin resistance in cervical cancer. Biomed Pharmacother 2022;153:113345. [PMID: 35810692 DOI: 10.1016/j.biopha.2022.113345] [Reference Citation Analysis]
3 Ran XQ, Gao L, Yan M, Kang CJ. Peroxiredoxin 4 Interacts With Domeless and Participates in Antibacterial Immune Response Through the JAK/STAT Pathway. Front Immunol 2022;13:907183. [PMID: 35711411 DOI: 10.3389/fimmu.2022.907183] [Reference Citation Analysis]
4 Danesh Pouya F, Rasmi Y, Nemati M. Signaling Pathways Involved in 5-FU Drug Resistance in Cancer. Cancer Invest 2022;:1-28. [PMID: 35320055 DOI: 10.1080/07357907.2022.2055050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Front Pharmacol 2022;13:821344. [DOI: 10.3389/fphar.2022.821344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xiong J, Nie M, Fu C, Chai X, Zhang Y, He L, Sun S, Papaccio G. Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells. Stem Cells International 2022;2022:1-16. [DOI: 10.1155/2022/1608806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhou XY, Dai HY, Zhang H, Zhu JL, Hu H. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer. J Clin Lab Anal 2022;:e24315. [PMID: 35244291 DOI: 10.1002/jcla.24315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Afroze N, Pramodh S, Shafarin J, Bajbouj K, Hamad M, Sundaram MK, Haque S, Hussain A. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa. Int J Mol Sci 2022;23:1707. [PMID: 35163629 DOI: 10.3390/ijms23031707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Front Pharmacol 2022;12:784335. [DOI: 10.3389/fphar.2021.784335] [Reference Citation Analysis]
10 Fan CS, Chen CC, Chen LL, Chua KV, Hung HC, Hsu JT, Huang TS. Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β-NF-κB/IRF3 and JAK2/TYK2-STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization. Cells 2022;11:229. [PMID: 35053345 DOI: 10.3390/cells11020229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hu QP, Yan HX, Peng F, Feng W, Chen FF, Huang XY, Zhang X, Zhou YY, Chen YS. Genistein protects epilepsy-induced brain injury through regulating the JAK2/STAT3 and Keap1/Nrf2 signaling pathways in the developing rats. Eur J Pharmacol 2021;912:174620. [PMID: 34752743 DOI: 10.1016/j.ejphar.2021.174620] [Reference Citation Analysis]
12 Pi YN, Guo JN, Lou G, Cui BB. Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer. Cancer Cell Int 2021;21:639. [PMID: 34852825 DOI: 10.1186/s12935-021-02333-9] [Reference Citation Analysis]
13 Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers (Basel) 2021;13:5748. [PMID: 34830902 DOI: 10.3390/cancers13225748] [Reference Citation Analysis]
14 Pandey P, Khan F, Qari HA, Oves M. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention. Pharmaceuticals (Basel) 2021;14:1069. [PMID: 34832851 DOI: 10.3390/ph14111069] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhu J, Kamara S, Wang Q, Guo Y, Li Q, Wang L, Chen J, Du Q, Du W, Chen S, Zhu S, Chen J, Chu M, Zhang L. Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells. Front Cell Dev Biol 2021;9:677867. [PMID: 34109181 DOI: 10.3389/fcell.2021.677867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Medda A, Duca D, Chiocca S. Human Papillomavirus and Cellular Pathways: Hits and Targets. Pathogens 2021;10:262. [PMID: 33668730 DOI: 10.3390/pathogens10030262] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]